Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | ERCC1 | P07992 | 4/20 | 0.53 |
| ▸ | ERCC4 | Q92889 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.48 |
| ▸ | GRK2 | P25098 | 2/20 | 0.46 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21747434 | 0.82 | ALDH1A1 (0.50) | L3MBTL1ERCC1ERCC4ALDH1A1GAA | |
| SCHEMBL1623733 | 0.81 | ERCC1 (0.54) | ERCC1ERCC4ALDH1A1LMNAGAA | |
| SCHEMBL1561387 | 0.81 | MAPT (0.70) | L3MBTL1ERCC1ERCC4ALDH1A1LMNA | |
| SCHEMBL5443604 | 0.80 | CA12 (0.52) | L3MBTL1ALDH1A1LMNAGAAKMT2A | |
| SCHEMBL1627561 | 0.80 | L3MBTL1 (0.65) | L3MBTL1ALDH1A1LMNAKDM4EKMT2A | |
| SCHEMBL2321477 | 0.80 | MAPT (0.54) | L3MBTL1ALDH1A1LMNAGAAKDM4E | |
| SCHEMBL2319538 | 0.80 | CA12 (0.52) | L3MBTL1ALDH1A1LMNAGAAKDM4E | |
| SCHEMBL21834459 | 0.80 | ALDH1A1 (0.51) | ERCC1ERCC4ALDH1A1LMNAGAA | |
| SCHEMBL1174341 | 0.79 | PKM (0.56) | ERCC1ERCC4ALDH1A1LMNAGAA | |
| SCHEMBL26333385 | 0.79 | ERCC1 (0.53) | ERCC1ERCC4ALDH1A1LMNAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109331868-B | Phenylglycine bifunctional catalyst, and preparation method and application thereof | 广东工业大学 | 2021-03-26 | — | — | CN | claimed |
| CN-109331868-A | A kind of phenylglycine class bifunctional catalysis' agent and its preparation method and application | 广东工业大学 | 2019-02-15 | — | — | CN | claimed |
| EP-2965755-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES | Inoxia Lifesciences GmbH (AT) | 2016-01-13 | — | — | EP | claimed |
| EP-2528595-B1 | COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES | INOXIA LIFESCIENCES GMBH (AT) | 2015-08-05 | — | — | EP | claimed |
| US-20130065962-A1 | Compounds For Use In The Treatment Of Diseases | INOXIA LIFESCIENCES GMBH (AT) | 2013-03-14 | — | — | US | claimed |
| EP-2528595-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES | Inoxia Lifesciences GmbH (AT) | 2012-12-05 | — | — | EP | claimed |
| WO-2011091461-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES | PLANTA NATURSTOFFE VERTRIEBSGES.M.B.H. (AT) | 2011-08-04 | — | — | WO | claimed |
| CN-116283658-B | Hydrazide hydrazone HIF-2 alpha inhibitor and application thereof | 浙江大学医学院附属第一医院 | 2025-04-25 | — | — | CN | disclosed |
| CN-116283658-A | Hydrazide hydrazone HIF-2 alpha inhibitor and application thereof | 浙江大学医学院附属第一医院 | 2023-06-23 | — | — | CN | disclosed |
| EP-3656847-B1 | ADDITIVE COMPOSITION FOR CULTURE MEDIUM, ADDITIVE COMPOUND FOR CULTURE MEDIUM, AND METHOD FOR CULTURE OF CELLS OR TISSUE USING SAME | NISSAN CHEMICAL CORP (JP) | 2022-08-17 | — | — | EP | disclosed |
| US-20210353683-A1 | ADDITIVE FOR MEDIUM FOR PROMOTING PRODUCTION OF PARACRINE FACTOR | NISSAN CHEMICAL CORPORATION (JP) | 2021-11-18 | — | — | US | disclosed |
| US-20210253518-A1 | KINASE INHIBITOR | NISSAN CHEMICAL CORPORATION (JP) | 2021-08-19 | — | — | US | disclosed |
| US-20210253518-A1 | KINASE INHIBITOR | NISSAN CHEMICAL CORPORATION (JP) | 2021-08-19 | — | — | US | disclosed |
| US-20070135499-A1 | Hydrazide compounds | AERIE PHARMACEUTICALS, INC. (US) | 2007-06-14 | — | — | US | disclosed |
| WO-2006133216-A2 | 4-SUBSTITUTED ARYLAMINE DERIVATIVES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS | SMITHKLINE BEECHAM CORPORATION (US) | 2006-12-14 | — | — | WO | disclosed |
| EP-0942924-A2 | METHODS AND COMPOUNDS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS | Elan Pharmaceuticals, Inc. (US) | 1999-09-22 | — | — | EP | disclosed |
| US-5935983-A | FOR TREATMENT OF RESTENOSIS | BAYER AKTIENGESELLSCHAFT (DE) | 1999-08-10 | — | — | US | disclosed |
| WO-1998022494-A9 | METHODS AND COMPOUNDS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR SYNTHESIS | — | 1998-08-20 | — | — | WO | disclosed |
| WO-1998022494-A2 | METHODS AND COMPOUNDS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR SYNTHESIS | ELAN PHARMACEUTICALS, INC. (US) | 1998-05-28 | — | — | WO | disclosed |
| CN-1137380-A | Use of phenylcyclohexylcarboxamides | BAYER AG (DE) | 1996-12-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130065962-A1 | Compounds For Use In The Treatment Of Diseases | SLC10A1, CYP27A1, OAT | L3MBTL1 3028/4885ERCC1 3602/4885ERCC4 1912/4885 |
| US-20210253518-A1 | KINASE INHIBITOR | LATS2, LATS1, MAP3K6 | L3MBTL1 674/4885ERCC1 4451/4885ERCC4 4571/4885 |
| US-20210353683-A1 | ADDITIVE FOR MEDIUM FOR PROMOTING PRODUCTION OF PARACRINE FACTOR | HGF, HDGF, FGF2 | L3MBTL1 4707/4885ERCC1 4776/4885ERCC4 4349/4885 |
| US-20070135499-A1 | Hydrazide compounds | GRK4, GRK2, GRK1 | L3MBTL1 4643/4885ERCC1 2781/4885ERCC4 2950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.